With new advances in the Cushings space, we asked Dr. Maria Fleseriu, Professor of Medicine and Neurological Surgery and Director of the Pituitary Center at Oregon Health and Science University in Portland, Oregon, USA, to give us a rundown of the latest on medical therapies for Cushing’s Disease and Cushing’s Syndrome. Dr. Fleseriu gave us an insider’s view on one of the latest recently finalized phase 3 trials of a new potential drug called Levoketoconazole. The Drug is expected to be submitted for approval in the first quarter of 2021.
© 2020, Pituitary World News. All rights reserved.